| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $2,000,000 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Cherington Charles | 10 percent owner | 1 | $2M | 0 | $0 | $2M |
Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory cytokines, namely IL-7 and IL-15, intended for the treatment of ovarian cancer. Additionally, Ernexa is developing ERNA-102, an iMSC product engineered …
Over the last 12 months, insiders at Ernexa Therapeutics Inc. have bought $2M and sold $0 worth of Ernexa Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Ernexa Therapeutics Inc. have bought $7,999.87B and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Cherington Charles (10 percent owner) — $2M.
The last purchase of 4,000,000 shares for transaction amount of $2M was made by Cherington Charles (10 percent owner) on 2026‑02‑10.
| 2026-02-10 | Cherington Charles | 10 percent owner | 4M 83.4958% | $0.50 | $2M | -34.40% | ||
| 2025-06-09 | Cherington Charles | 10 percent owner | 21.24M 18.8502% | $0.10 | $2.22M | -56.34% | ||
| 2025-04-02 | Cherington Charles | 10 percent owner | 3.77M 3.9501% | $0.10 | $394,174 | -52.61% | ||
| 2024-10-29 | Cherington Charles | 10 percent owner | 13.25M – | $2.41M | $31,999.46B | -81.70% | ||
| 2024-09-24 | Cherington Charles | 10 percent owner | 13.25M 20.0594% | $0.33 | $4.38M | -78.55% | ||
| 2022-12-02 | Cherington Charles | director | 261,756 3.9322% | $3.28 | $858,560 | -16.36% | ||
| 2022-12-02 | HALPERN JOHN D | director | 335,920 5.0463% | $3.28 | $1.1M | -16.36% | ||
| 2022-12-02 | Singer Nicholas Jason | director | 283,286 4.2556% | $3.28 | $929,178 | -16.36% | ||
| 2021-07-14 | DENNY GEORGE P III | 10 percent owner | 1 <0.0001% | $11.99 | $12 | -69.43% | ||
| 2021-07-09 | DENNY GEORGE P III | 10 percent owner | 1 <0.0001% | $14.11 | $14 | -70.12% | ||
| 2021-07-08 | DENNY GEORGE P III | 10 percent owner | 1 <0.0001% | $14.35 | $14 | -71.92% | ||
| 2021-07-06 | Sale | DENNY GEORGE P III | 10 percent owner | 75,000 5.5174% | $16.06 | $1.2M | -73.58% | |
| 2021-06-17 | Sale | Cherington Charles | 200,000 14.426% | $15.75 | $3.15M | -67.47% | ||
| 2021-06-16 | Sale | Cherington Charles | 200,000 14.412% | $15.73 | $3.15M | -67.72% | ||
| 2020-08-13 | Sale | ELLIN ROBERT S | 10 percent owner | 327,650 8.3217% | $5.55 | $1.82M | -26.35% | |
| 2020-06-17 | Sale | ELLIN ROBERT S | 10 percent owner | 12,400 0.3413% | $6.01 | $74,524 | -5.23% | |
| 2020-06-16 | Sale | ELLIN ROBERT S | 10 percent owner | 100 0.0018% | $3.86 | $386 | -49.67% | |
| 2020-06-03 | Sale | Berg Jeffrey Alan | 10 percent owner | 21,932 0.1102% | $1.10 | $24,059 | +83.75% | |
| 2020-06-02 | Sale | Berg Jeffrey Alan | 10 percent owner | 30,730 0.1393% | $0.99 | $30,423 | +131.05% | |
| 2020-06-01 | Sale | Berg Jeffrey Alan | 10 percent owner | 30,000 0.1455% | $1.06 | $31,770 | +104.67% |
| Cherington Charles | 10 percent owner | 6779440 415.3023% | $13.69M | 5 | 2 | <0.0001% |
| BROADWOOD PARTNERS, L.P. | 29971561 1836.0304% | $60.54M | 15 | 0 | ||
| BRADSHER NEAL C | 9322262 571.0733% | $18.83M | 3 | 0 | ||
| Trinad Capital Master Fund Ltd. | 10 percent owner | 8900093 545.2116% | $17.98M | 41 | 0 | |
| WEST MICHAEL D | Co-Chief Executive Officer | 882864 54.0834% | $1.78M | 3 | 1 | |
| HALPERN JOHN D | director | 450961 27.6255% | $910,941.22 | 1 | 0 | |
| BUSH MICHAEL J | CEO | 300478 18.407% | $606,965.56 | 14 | 0 | |
| Berg Jeffrey Alan | 10 percent owner | 276100 16.9136% | $557,722.00 | 26 | 9 | |
| Khuchua Vladimir | EVP and Chief Product Officer | 272700 16.7054% | $550,854.00 | 4 | 0 | |
| Singer Nicholas Jason | director | 266214 16.308% | $537,752.28 | 1 | 0 | |
| Yanover Paul | director | 205000 12.5581% | $414,100.00 | 2 | 0 | |
| LICHTINGER PEDRO | director | 126250 7.734% | $255,025.00 | 2 | 0 | |
| Farricielli Joseph J. Jr. | director | 110000 6.7385% | $222,200.00 | 15 | 0 | |
| Keymer Kenneth L | director | 98100 6.0095% | $198,162.00 | 3 | 0 | |
| FARRELL STEPHEN C | director | 97450 5.9697% | $196,849.00 | 6 | 0 | |
| Wolff Allen | CFO and EVP | 95500 5.8502% | $192,910.00 | 3 | 0 | |
| MOHANTY ADITYA P. | Co-Chief Executive Officer | 89696 5.4947% | $181,185.92 | 1 | 0 | |
| Santana Dario Loreto | President and CEO | 75000 4.5944% | $151,500.00 | 1 | 0 | |
| Russell Angus C. | director | 67500 4.135% | $136,350.00 | 1 | 0 | |
| Simtob Richard Isaac | director | 52088 3.1909% | $105,217.76 | 3 | 0 | |
| CLASEN ROBERT B | director | 50000 3.063% | $101,000.00 | 1 | 0 | |
| SCHLACHET DAVID | director | 32050 1.9634% | $64,741.00 | 1 | 0 | |
| Bourbiel Jennifer | Vice President, Marketing | 15000 0.9189% | $30,300.00 | 1 | 0 | |
| Mitgang Steve | director | 15000 0.9189% | $30,300.00 | 2 | 0 | |
| ARLEN GARY H | director | 10450 0.6402% | $21,109.00 | 1 | 0 | |
| COHEN ABRAHAM E | director | 10000 0.6126% | $20,200.00 | 1 | 0 | |
| Lewis Mary Beth | director | 10000 0.6126% | $20,200.00 | 1 | 0 | |
| Glassman Nicholas A | EVP of Product and Technology | 10000 0.6126% | $20,200.00 | 1 | 0 | |
| Uphoff Tony | director | 9600 0.5881% | $19,392.00 | 1 | 0 | |
| GARCIA PETER S | Chief Financial Officer | 7000 0.4288% | $14,140.00 | 2 | 0 | |
| Krishnan Ram | CEO | 5900 0.3614% | $11,918.00 | 4 | 0 | |
| Miller Dave Brian | SVP Marketing | 5600 0.3431% | $11,312.00 | 6 | 0 | |
| SKIBSTED RUSSELL | Chief Financial Officer | 2000 0.1225% | $4,040.00 | 1 | 0 | |
| George Christopher Allen | SVP and CHIEF INFORMATION OFF | 600 0.0368% | $1,212.00 | 1 | 0 | |
| BERGER FRANKLIN M | director | 500 0.0306% | $1,010.00 | 1 | 0 | |
| ELLIN ROBERT S | 10 percent owner | 421 0.0258% | $850.42 | 21 | 4 | |
| DENNY GEORGE P III | 10 percent owner | 3 0.0002% | $6.06 | 3 | 1 |
$6,974,678 | 45 | -14.98% | $4.63M | |
$633,070 | 27 | -5.89% | $2.04M | |
$8,249,886 | 17 | -47.87% | $399,787.00 | |
$117,515 | 16 | -27.38% | $1.66M | |
$24,098 | 12 | -21.64% | $1.44M |
| Increased Positions | 6 | +40% | 41,969 | +8.12% |
| Decreased Positions | 4 | -26.67% | 36,199 | -7% |
| New Positions | 3 | New | 14,029 | New |
| Sold Out Positions | 3 | Sold Out | 36,152 | Sold Out |
| Total Postitions | 17 | +13.33% | 522,698 | +1.12% |
| Corient Private Wealth Llc | $508.00 | 5.48% | 438,092 | +420,569 | +2,400.1% | 2025-09-30 |
| Susquehanna International Group, Llp | $36.00 | 0.39% | 30,854 | +30,854 | New | 2025-09-30 |
| Geode Capital Management, Llc | $24.00 | 0.26% | 20,453 | +378 | +1.88% | 2025-09-30 |
| Vanguard Group Inc | $13.00 | 0.14% | 11,147 | +11,147 | New | 2025-09-30 |
| Sippican Capital Advisors | $12.00 | 0.13% | 10,000 | 0 | 0% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $6.00 | 0.07% | 5,182 | +5,182 | New | 2025-09-30 |
| Blackrock, Inc. | $1.00 | 0.01% | 820 | 0 | 0% | 2025-09-30 |
| Assetmark, Inc | $0 | <0.01% | 133 | 0 | 0% | 2025-09-30 |
| Eversource Wealth Advisors, Llc | $0 | <0.01% | 116 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $0 | <0.01% | 77 | -477 | -86.1% | 2025-09-30 |